Cardiff Park Advisors’s GSK GSK Stock Holding History

Cardiff Park Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$360K	Buy	+6,520	New	+$353K	0.03%	213
2025 Q4	–	Sell	-7,520	Closed	-$325K	–	366
2025 Q3	$325K	Buy	+7,520	New	+$294K	0.02%	226
2024 Q2	–	Sell	-14,959	Closed	-$641K	–	346
2024 Q1	$641K	Buy	+14,959	New	+$617K	0.06%	139
2022 Q4	–	Sell	-11,008	Closed	-$324K	–	319
2022 Q3	$324K	Buy	11,008 +83	+0.8%	+$3.15K	0.05%	178
2022 Q2	$594K	Buy	10,925 +138	+1%	+$7.62K	0.09%	123
2022 Q1	$587K	Buy	10,787 +119	+1%	+$6.46K	0.08%	126
2021 Q4	$588K	Buy	+10,668	New	+$555K	0.08%	127

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cardiff Park Advisors's GSK Position: Q1 2026 in Review

Cardiff Park Advisors opened a new position in GSK (GSK) in Q1 2026: 6,520 shares worth $360K. The stake represents 0.03% of the portfolio and ranks #213 among its holdings. This is a return to the name: Cardiff Park Advisors previously reported a position in GSK as recently as Q3 2025.

Cardiff Park Advisors first reported a position in GSK in Q4 2021 and has held it in 7 quarters since. The position peaked at $641K in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Cardiff Park Advisors held 6,520 shares of GSK worth $360K as of Q1 2026.
GSK was a new Cardiff Park Advisors position in Q1 2026.
GSK made up 0.03% of Cardiff Park Advisors's portfolio in Q1 2026, its #213 holding.
Cardiff Park Advisors first reported a position in GSK in Q4 2021 and has held it in 7 quarters since.
Cardiff Park Advisors's GSK position peaked at $641K in Q1 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.